Amyloidosis

Two Alzheimer's drugs, lecanemab and donanemab, have been approved in the US. At a recent gathering organized by the Goulandris Foundation and the Hellenic Initiative Against Alzheimer's, new research on lecanemab was presented.

Investor and co-founder of Google Maps Lars Rasmussen has decided to invest in the Greek biotechnology company ResQ Biotech, it was reported on Tuesday.

The approval by the US Food and Drug Administration last Thursday of the antibody treatment Leqembi, which significantly slows the progression of Alzheimer's in its early stages, has given hope to millions of patients and their families. 

The drug is the fruit of the collaboration between American biotechnology company Biogen and Japan's Eisai.